Viraldine

Viraldine.com sells a single product line: a 10 % povidone-iodine antiseptic nasal spray sold in 20 ml and 50 ml amber glass bottles. Price points sit in the budget-to-mid range: $14.95 for the travel size and $24.95 for the full size, with multipack discounts that drop the unit cost below $20. Sales are online-only through the brand’s Shopify storefront and Amazon marketplace; no retail pharmacy listings are offered. The brand’s entire positioning is built around “nasal hygiene” for airborne pathogens, a niche most OTC iodine products ignore. Viraldine formulates at the exact 1 % available-iodine level referenced in published in-vitro studies on SARS-CoV-2, markets a USP-grade excipient list, and ships each lot with a publicly viewable microbial-testing certificate. Its dark-glass, metered-spray packaging is designed to avoid the plastic leaching and dose inconsistency that plague compounded iodine rinses. Core buyers are health-security-conscious professionals, frequent flyers, teachers, and parents who want an evidence-backed, drug-free adjunct to masking and vaccination. They value transparency (full label disclosure, USA manufacturing, third-party lab links) and prefer a portable spray over neti pots or squeeze bottles. Viraldine competes in the crowded “immune support” nasal spray set—xylitol, saline, essential-oil, and colloidal-silver sprays—by offering the only povidone-iodine consumer SKU in ready-to-use spray form. Its differentiation hinges on clinical-grade antiseptic credibility, transparent quality documentation, and sub-$25 pricing that undercuts both prescription iodine preparations and high-end natural sprays while still delivering pharmaceutical-level potency.